Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00007787 · ClinicalTrials.gov registry record · NA
Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants
A NA study of Kidney Transplantation and Chronic Allograft Nephropathy, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT00007787: Completed NA study of Kidney Transplantation and Chronic Allograft Nephropathy, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00007787 is a NA study of Kidney Transplantation and Chronic Allograft Nephropathy that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 350 participants, above the 257-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (36% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00007787, a NA study of Kidney Transplantation and Chronic Allograft Nephropathy, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if kidney function can be improved during transplants by giving the drug Thymoglobulin with delayed cyclosporine treatment instead of initial cyclosporine treatment. There have been improvements for patients receiving kidney transplants, yet acute rejection is still a problem. This can lead to kidney failure over time. Patients whose graft fails to function properly in the first week after transplant do not do as well after 5 years as compared to patients without early problems. This study will see if Thymoglobulin, a drug that suppresses the immune system, will improve early graft function.
Primary Outcome
measured by a calculated creatinine clearance. Creatinine Clearance for males will be computed using the following: \[weight in kg \* (140 - age in years)\]/ \[72 \* serum creatinine mg/dl\]. For females, eighty-five percent of this value will be used.
Conditions Studied
Interventions
- DRUG Tacrolimus
- BIOLOGICAL Cyclosporine
- BIOLOGICAL Anti-human thymocyte globulin (rabbit)
Study Locations (1)
Maryland
- Ilene Blechman-Krom - Rockville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2000-04 |
| Est. Completion | 2004-03 |
| Phase | NA |
What the finished NCT00007787 record still lists
NCT00007787 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, above the 257-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (36% higher).
The record links to 2 conditions, with Kidney Transplantation appearing as the primary indexed condition, and to 3 interventions - of which Tacrolimus is the first listed.
NCT00007787 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00007787 about?
NCT00007787 is a clinical study titled "Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants". The purpose of this study is to see if kidney function can be improved during transplants by giving the drug Thymoglobulin with delayed cyclosporine treatment instead of initial cyclosporine treatment. There have been improvements for patients receiving kidney transplants, yet acute rejection is st...
What is the current status of trial NCT00007787?
This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2000-04. Estimated completion is 2004-03.
What conditions does trial NCT00007787 study?
This clinical trial studies the following conditions: Kidney Transplantation, Chronic Allograft Nephropathy.
What interventions are being tested in trial NCT00007787?
The interventions under investigation include: Tacrolimus (DRUG), Cyclosporine (BIOLOGICAL), Anti-human thymocyte globulin (rabbit) (BIOLOGICAL).
Who is sponsoring clinical trial NCT00007787?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00007787 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00007787's enrollment target sits among peer trials
350 5th of 33 higher than 28 of 33 other Kidney Transplantation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Transplantation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Prehabilitation for Kidney Transplant Candidates
RECRUITING · NA
-
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
RECRUITING · NA
-
APOL1 Genetic Testing Program for Living Donors
ACTIVE NOT RECRUITING · NA
-
Watermelon/UBIQuinone Study
ACTIVE NOT RECRUITING · NA
-
Vitamin D Replacement After Kidney Transplant
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia